EI Ventures, a startup studio founded in 2021, focused its investments on seed-stage, early-stage, and later-stage companies. The firm primarily targeted sectors such as decentralized finance, blockchain technology, fintech, and cryptocurrency, and also made investments in the beverages, internet software, and business/productivity software industries.
67% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (67% of deals). Average disclosed round size is $74.3M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Unstoppable Domains | Series A | $65M | Jul 2022 |
 Scenic Biotech | Series A | $31M | Mar 2022 |
 IO Biotech | Series B | $127M | Jan 2021 |
Top Co-Investors
Vivo Capital1 shared
Kurma Partners1 shared
RA Capital Management1 shared
Samsara BioCapital1 shared
Idinvest1 shared
PFM Health Sciences1 shared
Soleus Capital1 shared
Sunstone Life Science Ventures1 shared
Mayfield Fund1 shared
Pantera1 shared
Gaingels1 shared
Alchemy Ventures1 shared
Redbeard Ventures1 shared
Spartan Group1 shared
OKG Investments1 shared
Polygon1 shared
CoinDCX1 shared
CoinGecko1 shared
Rainfall Capital1 shared
Broadhaven1 shared
Last updated: 16 April 2026